Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2008-02, Vol.111 (4), p.1774-1780
Hauptverfasser:	Kantarjian, Hagop, Schiffer, Charles, Jones, Dan, Cortes, Jorge
Format:	Artikel
Sprache:	eng
Schlagworte:	Chromosome Banding DNA Mutational Analysis Drug Monitoring Enzyme Inhibitors - therapeutic use Fusion Proteins, bcr-abl Gene Rearrangement Humans In Situ Hybridization, Fluorescence Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology Polymerase Chain Reaction Protein-Tyrosine Kinases - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!